FDG PET in Prostate Cancer

被引：34
|
作者：
Jadvar, Hossein [1 ]
机构：
[1] Univ Southern Calif, Keck Sch Med, Dept Radiol, Div Nucl Med, 2250 Alcazar St,CSC 102, Los Angeles, CA 90033 USA
来源：
PET CLINICS | 2009年 / 4卷 / 02期
基金：
美国国家卫生研究院;
关键词：
PET; CT; FDG; Prostate; Cancer;
D O I：
10.1016/j.cpet.2009.05.002
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
The role of positron emission tomography (PET) with [F-18]-fluorodeoxyglucose (FDG) for the imaging evaluation of patients who have cancer has expanded rapidly worldwide. The exact clinical use of PET and PET-computed tomography in prostate cancer is currently being explored. The recent publications summarizing the NOPR findings showed that prostate cancer was one of the most common cancers with patient enrollment. This article first reviews the limited available data on the molecular biology basis of FDG accumulation in prostate cancer, and then briefly reviews the current clinical experience with the use of PET with FDG in the imaging evaluation of prostate cancer.
引用
收藏
页码：155 / +
页数：8
相关论文
共 50 条
  • [1] PET Tracers Beyond FDG in Prostate Cancer
    Schuster, David M.
    Nanni, Cristina
    Fanti, Stefano
    SEMINARS IN NUCLEAR MEDICINE, 2016, 46 (06) : 507 - 521
  • [2] Is There Use for FDG-PET in Prostate Cancer?
    Jadvar, Hossein
    SEMINARS IN NUCLEAR MEDICINE, 2016, 46 (06) : 502 - 506
  • [3] FDG PET in suspected recurrent and metastatic prostate cancer
    Jadvar, H
    Pinski, JK
    Conti, PS
    ONCOLOGY REPORTS, 2003, 10 (05) : 1485 - 1488
  • [4] Recurrent prostate cancer and FDG PET: a misconstrued resource?
    Elmes, M.
    Davidson, A.
    Minor, T.
    Bolton, D.
    Scott, A.
    BJU INTERNATIONAL, 2007, 99 : 9 - 9
  • [5] The Use of FDG-PET in conjunction with PSMA-PET in Prostate Cancer
    Gokhale, Saket
    Kuang, Angie
    Teichner, Eric
    Subtirelu, Robert
    Werner, Thomas
    Hoilund-Carlsen, Poul Flemming
    Revheim, Mona-Elisabeth
    Alavi, Abass
    Raynor, William
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64
  • [6] FDG-PET Versus PSMA-PET: A Patient With Prostate Cancer
    Kichloo, Asim
    Amir, Rawan
    Aljadah, Michael
    Wani, Farah
    Solanki, Shantanu
    Singh, Jagmeet
    Chugh, Savneek Singh
    JOURNAL OF INVESTIGATIVE MEDICINE HIGH IMPACT CASE REPORTS, 2020, 8
  • [7] Role of FDG PET/CT in Management of Patients with Prostate Cancer
    Sutherland, Duncan E. K.
    Azad, Arun A.
    Murphy, Declan G.
    Eapen, Renu S.
    Kostos, Louise
    Hofman, Michael S.
    SEMINARS IN NUCLEAR MEDICINE, 2024, 54 (01) : 4 - 13
  • [8] FDG PET/CT in Prostate Metastasis From Gastric Cancer
    Ji, Xia
    Dong, Aisheng
    CLINICAL NUCLEAR MEDICINE, 2022, 47 (10) : 918 - 920
  • [9] Utility of FDG-PET in clinical neuroendocrine prostate cancer
    Spratt, Daniel E.
    Gavane, Somali
    Tarlinton, Lisa
    Fareedy, Shoaib B.
    Doran, Michael G.
    Zelefsky, Michael J.
    Osborne, Joseph R.
    PROSTATE, 2014, 74 (11): : 1153 - 1159
  • [10] FDG PET/CT in Peritoneal Metastasis From Prostate Cancer
    Gungor, Serkan
    Asa, Sertac
    Kupik, Osman
    CLINICAL NUCLEAR MEDICINE, 2016, 41 (09) : E424 - E425
12345